全文获取类型
收费全文 | 68709篇 |
免费 | 4536篇 |
国内免费 | 180篇 |
专业分类
耳鼻咽喉 | 768篇 |
儿科学 | 2662篇 |
妇产科学 | 1656篇 |
基础医学 | 8481篇 |
口腔科学 | 714篇 |
临床医学 | 10225篇 |
内科学 | 12153篇 |
皮肤病学 | 917篇 |
神经病学 | 6529篇 |
特种医学 | 1437篇 |
外国民族医学 | 7篇 |
外科学 | 7252篇 |
综合类 | 756篇 |
一般理论 | 118篇 |
预防医学 | 8913篇 |
眼科学 | 955篇 |
药学 | 4430篇 |
1篇 | |
中国医学 | 80篇 |
肿瘤学 | 5371篇 |
出版年
2023年 | 324篇 |
2022年 | 210篇 |
2021年 | 1057篇 |
2020年 | 860篇 |
2019年 | 1334篇 |
2018年 | 1533篇 |
2017年 | 1257篇 |
2016年 | 1302篇 |
2015年 | 1562篇 |
2014年 | 2187篇 |
2013年 | 3385篇 |
2012年 | 4902篇 |
2011年 | 5285篇 |
2010年 | 2919篇 |
2009年 | 2639篇 |
2008年 | 4780篇 |
2007年 | 5139篇 |
2006年 | 4920篇 |
2005年 | 5012篇 |
2004年 | 4712篇 |
2003年 | 4415篇 |
2002年 | 4102篇 |
2001年 | 668篇 |
2000年 | 492篇 |
1999年 | 591篇 |
1998年 | 683篇 |
1997年 | 577篇 |
1996年 | 461篇 |
1995年 | 558篇 |
1994年 | 487篇 |
1993年 | 413篇 |
1992年 | 359篇 |
1991年 | 325篇 |
1990年 | 328篇 |
1989年 | 279篇 |
1988年 | 259篇 |
1987年 | 272篇 |
1986年 | 253篇 |
1985年 | 265篇 |
1984年 | 244篇 |
1983年 | 225篇 |
1982年 | 243篇 |
1981年 | 243篇 |
1980年 | 188篇 |
1979年 | 159篇 |
1978年 | 157篇 |
1977年 | 84篇 |
1976年 | 85篇 |
1975年 | 73篇 |
1974年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Thomas Behrens Calvin Ge Roel Vermeulen Benjamin Kendzia Ann Olsson Joachim Schüz Hans Kromhout Beate Pesch Susan Peters Lützen Portengen Per Gustavsson Dario Mirabelli Pascal Guénel Danièle Luce Dario Consonni Neil E. Caporaso Maria Teresa Landi John K. Field Stefan Karrasch Heinz-Erich Wichmann Jack Siemiatycki Marie-Elise Parent Lorenzo Richiardi Lorenzo Simonato Karl-Heinz Jöckel Wolfgang Ahrens Hermann Pohlabeln Guillermo Fernández-Tardón David Zaridze John R. McLaughlin Paul A. Demers Beata Świątkowska Jolanta Lissowska Tamás Pándics Eleonora Fabianova Dana Mates Vladimir Bencko Lenka Foretova Vladimír Janout Paolo Boffetta Bas Bueno-de-Mesquita Francesco Forastiere Kurt Straif Thomas Brüning 《International journal of cancer. Journal international du cancer》2023,152(4):645-660
There is limited evidence regarding the exposure-effect relationship between lung-cancer risk and hexavalent chromium (Cr(VI)) or nickel. We estimated lung-cancer risks in relation to quantitative indices of occupational exposure to Cr(VI) and nickel and their interaction with smoking habits. We pooled 14 case-control studies from Europe and Canada, including 16 901 lung-cancer cases and 20 965 control subjects. A measurement-based job-exposure-matrix estimated job-year-region specific exposure levels to Cr(VI) and nickel, which were linked to the subjects' occupational histories. Odds ratios (OR) and associated 95% confidence intervals (CI) were calculated by unconditional logistic regression, adjusting for study, age group, smoking habits and exposure to other occupational lung carcinogens. Due to their high correlation, we refrained from mutually adjusting for Cr(VI) and nickel independently. In men, ORs for the highest quartile of cumulative exposure to CR(VI) were 1.32 (95% CI 1.19-1.47) and 1.29 (95% CI 1.15-1.45) in relation to nickel. Analogous results among women were: 1.04 (95% CI 0.48-2.24) and 1.29 (95% CI 0.60-2.86), respectively. In men, excess lung-cancer risks due to occupational Cr(VI) and nickel exposure were also observed in each stratum of never, former and current smokers. Joint effects of Cr(VI) and nickel with smoking were in general greater than additive, but not different from multiplicative. In summary, relatively low cumulative levels of occupational exposure to Cr(VI) and nickel were associated with increased ORs for lung cancer, particularly in men. However, we cannot rule out a combined classical measurement and Berkson-type of error structure, which may cause differential bias of risk estimates. 相似文献
2.
Drug Safety - This real-world safety analysis was requested by the European Medicines Agency following approval of apremilast, an oral treatment for psoriasis or psoriatic arthritis. We aimed to... 相似文献
3.
Shira H. Fischer MD PhD Regina A. Shih PhD Tara L. McMullen PhD Maria O. Edelen PhD Sangeeta C. Ahluwalia PhD Emily K. Chen PhD Sarah E. Dalton MA Susan Paddock PhD Anthony Rodriguez PhD Debra Saliba MD MPH AGSF Stella Mandl BSW BSN RN Teresa Mota BSN RN Advisory Group on Medication Reconciliation in PAC 《Journal of the American Geriatrics Society》2022,70(4):1047-1056
4.
5.
6.
Tosi Umberto Maayan Omri An Anjile Lavieri Miguel E. Tusa Guadix Sergio W. DeRosa Antonio P. Christos Paul J. Pannullo Susan Stieg Philip E. Brandmaier Andrew Knisely Jonathan P. S. Ramakrishna Rohan 《Journal of neuro-oncology》2022,156(2):431-441
Journal of Neuro-Oncology - Neurofibromatosis type 2 (NF2) is characterized by often bilateral vestibular schwannomas (VS) that result in progressive hearing loss and compression of nearby... 相似文献
7.
8.
David A. Ganz MD PhD Anita H. Yuan PhD MPH Erich J. Greene PhD Nancy K. Latham PT PhD Katy Araujo MPH Albert L. Siu MD MSPH Jay Magaziner MSHyg PhD Jerry H. Gurwitz MD Albert W. Wu MD MPH Neil B. Alexander MD Robert B. Wallace MD MSc Susan L. Greenspan MD Jeremy Rich DPM Elena Volpi MD PhD Stephen C. Waring DVM PhD Patricia C. Dykes RN PhD MA Fred Ko MD MS Neil M. Resnick MD Siobhan K. McMahon PhD MPH GNP Shehzad Basaria MD Rixin Wang PhD Charles Lu MS Denise Esserman PhD James Dziura PhD Michael E. Miller PhD Thomas G. Travison PhD Peter Peduzzi PhD Shalender Bhasin MB BS David B. Reuben MD Thomas M. Gill MD 《Journal of the American Geriatrics Society》2022,70(11):3221-3229
9.
10.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献